Jonathan Anderman - Gen Counsel & Corporate Sec at Compass Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Gen Counsel & Corporate Sec
Stock Symbol
CMPX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Jonathan Anderman - trading volume in the past year for Compass Therapeutics, Inc.

Holdings reported by Jonathan Anderman for Compass Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21K $32.3K $1.54 Apr 7, 2025 Direct
Stock Option (Right to Buy) 280K Feb 11, 2025 Direct Common Stock

Transactions reported by Jonathan Anderman for Compass Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.